Study title: Erythrocyte Sodium-Lithium Countertransport and Proliferative Diabetic Retinopathy.Invest Ophthalmol Vis Sci. 2000 May;41(6):1482-5.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: | |||||
| Brands: | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: SODIUM CHROMATE | |||||
| ATC code: | |||||
| Document link: 2011-09 GE response Sodium Chromate List of published articles.doc | |||||
| Document date: 2013-11-08 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Review Article | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |